Departments of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Pediatr Infect Dis J. 2011 Sep;30(9):794-7. doi: 10.1097/INF.0b013e3182195808.
Posaconazole (PSZ) may be an attractive alternative for antifungal prophylaxis in children with chronic granulomatous disease. Experience with PSZ in pediatric patients is limited, and no specific dose recommendations exist. A twice daily dosing algorithm based on allometric scaling (body-weight based) for PSZ results in adequate exposure and appears to be safe in children with chronic granulomatous disease.
泊沙康唑(PSZ)可能是慢性肉芽肿病儿童抗真菌预防的一种有吸引力的选择。在儿科患者中使用 PSZ 的经验有限,并且不存在特定的剂量建议。基于 PSZ 体表面积比例法(基于体重)的每日两次给药方案可达到充分的暴露,并且在患有慢性肉芽肿病的儿童中似乎是安全的。